XT
SNDX icon

XTX Topco’s Syndax Pharmaceuticals SNDX Stock Holding History

XTX Topco’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Sell
59,164
-19,843
-25% -$413K 0.02% 1546
2026
Q1 		$1.85M Buy
79,007
+60,531
+328% +$1.32M 0.03% 900
2025
Q4 		$388K Sell
18,476
-11,917
-39% -$208K 0.01% 1837
2025
Q3 		$468K Buy
30,393
+18,434
+154% +$241K 0.02% 1130
2025
Q2 		$112K Sell
11,959
-51,767
-81% -$570K ﹤0.01% 1863
2025
Q1 		$783K Buy
+63,726
New +$899K 0.04% 709
2023
Q4 		– Sell
-29,864
Closed -$434K – 2098
2023
Q3 		$434K Buy
+29,864
New +$565K 0.07% 482

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

XTX Topco's SNDX Position: Q2 2026 in Review

XTX Topco reduced its Syndax Pharmaceuticals (SNDX) stake by 25% in Q2 2026, selling an estimated $413K and leaving 59,164 shares worth $1.29M. The position accounts for 0.02% of the portfolio, ranked #1546.

XTX Topco first reported a position in SNDX in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.85M in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • XTX Topco held 59,164 shares of Syndax Pharmaceuticals worth $1.29M as of Q2 2026.
  • XTX Topco sold 19,843 Syndax Pharmaceuticals shares in Q2 2026, an estimated $413K.
  • Syndax Pharmaceuticals made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1546 holding.
  • XTX Topco first reported a position in Syndax Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
  • XTX Topco's Syndax Pharmaceuticals position peaked at $1.85M in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.